Bupivacaine inhibits the malignant biological behavior of oral squamous cell carcinoma cells by inhibiting the activation of ERK1/2 and STAT3

Zhongchao Wang(Southwest Medical University), Liyuan Fan(Southwest Medical University)
Annals of Translational Medicine
May 1, 2021
Cited by 5


Related Papers